Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair
The Effect of Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair: Randomized Controlled Study
1 other identifier
interventional
36
1 country
1
Brief Summary
Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .. Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedStudy Start
First participant enrolled
July 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedAugust 2, 2024
August 1, 2024
6 months
February 13, 2024
August 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Visual Analog Scale (VAS)
In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.
Baseline
Visual Analog Scale (VAS)
In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.
6th week
Visual Analog Scale (VAS)
In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.
10th week
Shoulder joint range of motion (ROM)
Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.
Baseline
Shoulder joint range of motion (ROM)
Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.
6th week
Shoulder joint range of motion (ROM)
Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.
10 th week
Secondary Outcomes (6)
Shoulder Pain and Disability Index (SPADİ)
Baseline
Shoulder Pain and Disability Index (SPADİ)
6th week
Shoulder Pain and Disability Index (SPADİ)
10th week
Modified Constant-Murley Scoring
6th week
Modified Constant-Murley Scoring
10th week
- +1 more secondary outcomes
Study Arms (2)
Experimental Group
EXPERIMENTALIn addition to the conventional physiotherapy program, patients in the intervention group will receive a suprascapular nerve block with musculoskeletal USG guidance available in our clinic at the beginning of rehabilitation. Bupivacaine hydrochloride will be used in this injection. 5 ml of bupivacaine hydrochloride 5% and 5 ml of saline will be drawn into a 10 ml syringe and ejection will be performed from the superior of the suprascapular noch under USG guidance.
Control Group
ACTIVE COMPARATORPatients in the control group will only receive a conventional physiotherapy program.
Interventions
It will be applied to a rehabilitation program including joint range of motion exercises and physical therapy modalities by a physiotherapist at the Physical Therapy Hospital.
Bupivacaine hydrochloride will be used in this injection. 5 ml of bupivacaine hydrochloride 5% and 5 ml of saline will be drawn into a 10 ml syringe and ejection will be performed from the superior of the suprascapular noch under USG guidance.
Eligibility Criteria
You may qualify if:
- Having undergone arthroscopic rotator cuff repair surgery within the last week
You may not qualify if:
- History of previous surgery on the same shoulder
- History of systemic inflammatory rheumatological disease
- Neurological diseases with muscle weakness in the upper extremity (MS, ALS, Muscular -Dystrophy)
- History of malignancy, pregnancy, breastfeeding
- Use of steroids or immunosuppressive drugs
- History of allergic reactions to local analgesics
- Fibromyalgia syndrome
- Chronic painful conditions that require opioid use
- Presence of known psychiatric disease
- Cognitive impairment (Mini Mental Test Score \<23)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahi Evran University
Kirşehir, City Centre, 40100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Basak Cigdem Karacay, Asst Prof
Kirsehir Ahi Evran University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigator and outcome assessor will be different persons.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2024
First Posted
February 22, 2024
Study Start
July 28, 2024
Primary Completion
February 1, 2025
Study Completion
March 1, 2025
Last Updated
August 2, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share